AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $331 | -99.8% | 73,798 | +32.0% | 0.01% | -18.2% |
| Q3 2022 | $169,000 | -37.9% | 55,899 | +847.6% | 0.01% | -26.7% |
| Q3 2021 | $272,000 | -16.3% | 5,899 | 0.0% | 0.02% | -16.7% |
| Q2 2021 | $325,000 | +6.6% | 5,899 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $305,000 | +19.1% | 5,899 | 0.0% | 0.02% | +12.5% |
| Q4 2020 | $256,000 | +24.3% | 5,899 | 0.0% | 0.02% | +6.7% |
| Q3 2020 | $206,000 | – | 5,899 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |